Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear gene targeting using negatively charged liposomes.

C Welz1, W Neuhuber, H Schreier

  • 1Department of Pharmaceutics and Biopharmacy, Philipps University, Ketzerback 63, Marburg, Germany.

International Journal of Pharmaceutics
|March 4, 2000
PubMed
Summary

Chimeric oligonucleotides show promise for correcting genetic diseases. A novel AVE-3 liposomal formulation enhanced nuclear delivery of these DNA-analogue molecules.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining distal splenopancreatectomy by the mesopancreas.

Langenbeck's archives of surgery·2024
Same author

Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting - Synthesis and comparative in silico and in vitro assessment.

Carbohydrate research·2021
Same author

[Unclear massive hemorrhage with obstruction of the airways].

HNO·2021
Same author

Is binge-watching addictive? Effects of motives for TV series use on the relationship between excessive media consumption and problematic viewing habits.

Addictive behaviors reports·2021
Same author

Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation.

International journal of pharmaceutics·2020
Same author

Dental status does not predict infection during stem cell transplantation: a single-center survey.

Bone marrow transplantation·2017

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Nanotechnology

Background:

  • Oligonucleotides are valuable tools for controlling gene activity via base-pairing.
  • Chimeric oligonucleotides offer a new approach for correcting single-base mutations, potentially treating genetic diseases.

Purpose of the Study:

  • To investigate the intracellular fate of fluorescently labeled chimeric oligonucleotides.
  • To evaluate different liposomal formulations for delivering these molecules.

Main Methods:

  • A 68-mer DNA-analogue chimeric oligonucleotide was synthesized and fluorescently labeled.
  • Oligonucleotides were complexed with protamine sulfate and encapsulated in three liposomal formulations (AVE-3, neutral, negative).
  • Intracellular localization was tracked using fluorescence microscopy.

Related Experiment Videos

Main Results:

  • The AVE-3 liposomal formulation demonstrated superior properties compared to neutral and negatively charged formulations.
  • Nuclear localization of the chimeric oligonucleotides was exclusively observed with the AVE-3 formulation.
  • Only negatively charged liposomes interacted with the protamine-complexed oligonucleotides.

Conclusions:

  • The AVE-3 liposomal formulation significantly enhances the nuclear delivery of chimeric oligonucleotides.
  • This delivery system holds potential for gene correction strategies targeting nuclear DNA.
  • Further research into liposome-oligonucleotide interactions is warranted.